Navigation Links
Gene-Based Sunscreen Might Someday Prevent Skin Cancer

A topical drug could strengthen cells' DNA, animal studies suggest

FRIDAY, Dec. 7 (HealthDay News) -- Research is shedding new light on sunscreens that might someday prevent or treat skin cancer by reversing dangerous gene mutations caused by overexposure to the sun.

Working with hairless mice, researchers found that a synthetic compound called CP-31398 helped stabilize damage in the tumor-suppressing p53 gene. This type of damage occurs in humans and mice alike after sustained exposure to the sun's ultraviolet B (UVB) rays.

Once treated and repaired, the UVB-exposed p53 mouse gene resumed its normal cancer-preventing activity, inhibiting the spread and proliferation of tumor cells.

"Once the skin is exposed to UVB it leads to mutations in the p53 gene, and it becomes nonfunctional, and then you see induction of skin cancer " explained study lead author Mohammad Athar, a professor of dermatology at the University of Alabama, Birmingham.

"But this compound we used interacts with the p53 mutant genes and converts them back into functional genes," he said. "And that led to less incidence of skin cancer tumors, fewer numbers of tumors, and slower tumor growth in the UVB-exposed mice populations we tested."

Athar's findings are published in the December issue of The Journal of Clinical Investigation.

In all, the authors conducted four mouse experiments during which the animals were irradiated with UVB for periods of time ranging from 16 weeks to 40 weeks.

Some mice were given topical or injected versions of CP-31398, either immediately before a scheduled exposure to UVB, immediately following it, or for an extended period of weeks following discontinuation of all UVB exposure. For comparison purposes, other mice were not given CP-31398 at all.

CP-31398 seemed to prevent the onset of cancer altogether in UVB-exposed mice treated prior to the development of tumors, the team found.

As well, the compound appeared to limit the growth of skin tumors that had formed prior to the treatment's application.

In both cases, the observed success was attributed to the compound's ability to jumpstart proper p53 function, the researchers said.

Athar pointed out that p53 mutations linked to skin cancer are also present in more than half of all tumor types, so the current work could theoretically lead to cancer prevention applications for a range of diseases beyond melanoma.

"We tested UVB-signature mutations, but every cancer-causing agent that interacts with p53 has its own form of mutation," he noted. "So, we need to see if different types of cancers can be attenuated with this type of compound."

"We are also planning to conduct more studies in mice to see if the compound we used has any toxicity, although we did not find that to be the case so far," he said. "So, we are planning long-term studies with mice. Once that is complete, we will certainly go for clinical trials with humans."

In the interim, Dr. Robin Ashinoff , the medical director of dermatologic, mohs and laser surgery at Hackensack University Medical Center in Hackensack, N.J., said that the current findings should be viewed with a mix of interest and caution.

"This still needs to be studied in human trials in a placebo-controlled fashion," she noted. "And bringing this kind of technology to market is always a long road."

"But if we can work at the genetic level to try and prevent skin cancer where it starts and correct and suppress the abnormal clones that arise from UVB exposure, that would certainly be quite advantageous," she added. "And it would be wonderful to be able to put this approach into a creme or a sunblock. That -- when it happens -- will certainly become the new gold standard."

More information

For more on melanoma risk factors, visit the American Cancer Society.

SOURCES: Mohammad Athar, Ph.D., professor, dermatology, University of Alabama, Birmingham, Ala; Robin Ashinoff, M.D., medical director, dermatologic, mohs and laser surgery, Hackensack University Medical Center, Hackensack, N.J.; December 2007 The Journal of Clinical Investigation

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gene-Based Screen Spots Cervical Cancer Earlier
2. FDA Proposes New Rules for Sunscreens
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, Enough Is Enough
5. Fish Oil Might Help Relieve MS
6. HIV Drug Might Fight Cancer
7. High and mighty: first common height gene identified by researchers behind obesity gene finding
8. Vitamin C Plus Fat Might Spur Cancer
9. Mathematics might save you a trip to the ER
10. Veggies Might Ward Off Age-Linked Vision Woes
11. Rating your pain from 0 to 10 might not help your doctor
Post Your Comments:
Related Image:
Gene-Based Sunscreen Might Someday Prevent Skin Cancer
(Date:11/24/2015)... ... November 24, 2015 , ... Preparing for the LDT ... 3:00 p.m. EST, , FDA has long asserted that design and ... to performing the tests and do not meet the device regulations. , Come up ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... pleased to welcome Winter-Dent & Company as its newest Partner Firm. Based in ... become a client's most trusted advisor regardless of whether that client is a ...
(Date:11/24/2015)... ... ... With Thanksgiving right around the corner, holiday travel season is about to begin. ... vehicle. , According to the National Highway Traffic Safety Administration, 301 people were killed ... safety tips from the NHTSA: , Inspect tires ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... Dr. Rodney E. Willey , ... His new venture, Koala Center for Sleep Disorders, provides treatment for snoring and sleep ... who have opened a Koala Center for Sleep Disorders in the US, one of four ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Dr. Kevin ... office to help the community stress less this holiday season. During the Indiana ... stress in people's lives and the team at AlignLife want to help provide the ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24. November 2015 Avery Biomedical ... Systems, ist erfreut, die Berufung von Anders ... geben zu können. ... --> Foto -   ... Von 1984-1986 war er Fellow des Cardiovascular ...
(Date:11/24/2015)... India , November 24, 2015 ... market research report "Spine Biologics Market by Product Type (Bone ... (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End ... MarketsandMarkets, the global market was valued at $1.90 Billion in ... at a CAGR of 4.4% during the forecast period of ...
(Date:11/24/2015)... Nov. 24, 2015 Avery Biomedical Devices (ABD), ... to announce the appointment of Anders Jonzon , ... Dr. Jonzon is a ... Children,s Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... was a fellow at the Cardiovascular Institute (UCSF). His ...
Breaking Medicine Technology: